Clinical Trial Update: Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy of a therapy guided by fecal molecular antimicrobial susceptibility tests for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN